المؤلفون: Yan H; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China., Song L; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.; Department of Medical Oncology, Yiyang Central Hospital, Yiyang, 413000, China., Li Y; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China., Xu Q; Department of Medical Oncology, Qinghai Provincial People's Hospital, Xining, 810000, China., Guo W; Department of Pathology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 20025, China., Lin S; Department of Medical Oncology, The First Affiliated Hospital of Hunan University of Medicine, Huaihua, 418000, China., Jiang W; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China., Wang Z; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China., Deng L; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China., Huang Z; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China., Qin H; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China., Zhang X; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China., Tong F; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Zhang R; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Liu Z; Department of Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, 410008, Hunan, China., Zhang L; Department of Radiotherapy, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, 410008, Hunan, China., Yu J; Department of Medical Oncology, Zhangjiajie People's Hospital, Zhangjiajie, 410008, Hunan, China., Dong X; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Gong Q; Department of Good Clinical Trials, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, 410008, Hunan, China., Deng J; Early Clinical Trails Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, 410008, Hunan, China., Chen X; Early Clinical Trails Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, 410008, Hunan, China., Wang J; Early Clinical Trails Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, 410008, Hunan, China., Zhang G; Faculty of Dentistry, The University of Hong Kong, 34 Hospital Road, Sai Ying Pun, 999077, Hong Kong., Yang N; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China., Zhang Y; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China. zhangyongchang@csu.edu.cn.; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. zhangyongchang@csu.edu.cn.; Early Clinical Trails Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, 410008, Hunan, China. zhangyongchang@csu.edu.cn.; Furong Laboratory, Changsha, 410000, Hunan, China. zhangyongchang@csu.edu.cn., Zeng L; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China. 530490930@qq.com.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Mar 07; Vol. 73 (4), pp. 74. Date of Electronic Publication: 2024 Mar 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Microsatellite Instability* , Neoplasms*/drug therapy , Neoplasms*/genetics , Antibodies, Monoclonal, Humanized*, Humans ; Retrospective Studies ; China ; Pathologic Complete Response

المؤلفون: Gong J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, No. 52, Fucheng Road, Haidian District, Beijing, 100142, China., Cao J; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Zhang Q; Department of Mammary and Lymphatic Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Xu N; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Hangzhou, China., Zhao Y; Respiratory Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China., Xing B; Department of Hepatobiliary and Pancreatic Surgery, Peking University Cancer Hospital & Institute, Beijing, China., Miao Z; Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China., Wu Y; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangzhou, China., Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, Hangzhou, China., Gao Q; Department of Biotherapy, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China., Li X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Liu B; Department of Oncology, Nanjing Drum Tower Hospital, Nanjing, China., Li W; Department of Oncology, The First Bethune Hospital of Jilin University, Changchun, China., Pei Z; Department of Oncology, Luoyang Central Hospital, Luoyang, China., Xia H; CStone Pharmaceuticals (Suzhou) Co., Ltd, Suzhou, China., Qi Q; CStone Pharmaceuticals (Suzhou) Co., Ltd, Suzhou, China., Dai H; CStone Pharmaceuticals (Suzhou) Co., Ltd, Suzhou, China., Shi Q; CStone Pharmaceuticals (Suzhou) Co., Ltd, Suzhou, China., Yang J; CStone Pharmaceuticals (Suzhou) Co., Ltd, Suzhou, China., Li J; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, No. 150, Jimo Road, Pudong New District, Shanghai, 200120, China. lijin@csco.org.cn., Shen L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, No. 52, Fucheng Road, Haidian District, Beijing, 100142, China. shenlin@bjmu.edu.cn.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Aug; Vol. 71 (8), pp. 1897-1908. Date of Electronic Publication: 2022 Jan 05.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma*/drug therapy , Neoplasms*/pathology, Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized/adverse effects ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor ; China ; Humans ; Immune Checkpoint Inhibitors/adverse effects ; Immune Checkpoint Inhibitors/therapeutic use

المؤلفون: Ma S; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China., Hu X; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China., Cai W; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. Electronic address: caiws@sj-hospital.org.

المصدر: Early human development [Early Hum Dev] 2021 Mar; Vol. 154, pp. 105292. Date of Electronic Publication: 2020 Dec 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Ireland NLM ID: 7708381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-6232 (Electronic) Linking ISSN: 03783782 NLM ISO Abbreviation: Early Hum Dev Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/epidemiology , Neoplasms*/etiology , Prenatal Exposure Delayed Effects*/epidemiology, Birth Weight ; Case-Control Studies ; Child ; China/epidemiology ; Female ; Humans ; Pregnancy ; Retrospective Studies ; Risk Factors

المؤلفون: Wang L; Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University , Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy , Hangzhou, China.; Institute of Hematology, Zhejiang University , Hangzhou, China., Tan Su Yin E; Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University , Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy , Hangzhou, China.; Institute of Hematology, Zhejiang University , Hangzhou, China., Zhao H; Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University , Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy , Hangzhou, China.; Institute of Hematology, Zhejiang University , Hangzhou, China., Ni F; Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University , Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy , Hangzhou, China.; Institute of Hematology, Zhejiang University , Hangzhou, China., Hu Y; Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University , Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy , Hangzhou, China.; Institute of Hematology, Zhejiang University , Hangzhou, China., Huang H; Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University , Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy , Hangzhou, China.; Institute of Hematology, Zhejiang University , Hangzhou, China.

المصدر: Expert opinion on biological therapy [Expert Opin Biol Ther] 2020 Nov; Vol. 20 (11), pp. 1293-1308. Date of Electronic Publication: 2020 Jul 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/statistics & numerical data , Immunotherapy, Adoptive*/trends, Hematologic Neoplasms/*therapy , T-Lymphocytes/*transplantation, B-Lymphocytes/immunology ; China/epidemiology ; Combined Modality Therapy ; Hematologic Neoplasms/epidemiology ; Hematologic Neoplasms/immunology ; Hematologic Neoplasms/pathology ; Humans ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/therapy ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/immunology ; Receptors, Antigen, T-Cell/metabolism ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/immunology ; Receptors, Chimeric Antigen/metabolism ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism

المؤلفون: Wu J; Clinical Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Department of Clinical Research, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China., Zhang C; Department of Central Laboratory, People's Hospital of Taizhou, Taizhou, China., Zhang G; Hospital Office, People's Hospital of Gaozhou, Gaozhou, China., Wang Y; School of Public Health, Guangdong Medical University, Zhanjiang, China., Zhang Z; School of Public Health, Guangdong Medical University, Zhanjiang, China., Su W; Department of Oncology, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China., Lyu J; Clinical Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Chinalujun2006@xjtu.edu.cn.

المصدر: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology [Cell Physiol Biochem] 2018; Vol. 51 (2), pp. 575-588. Date of Electronic Publication: 2018 Nov 22.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: Cell Physiol Biochem Press GmbH & Co KG Country of Publication: Germany NLM ID: 9113221 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9778 (Electronic) Linking ISSN: 10158987 NLM ISO Abbreviation: Cell Physiol Biochem Subsets: MEDLINE

مواضيع طبية MeSH: Apolipoprotein A-I/*blood , Neoplasms/*diagnosis, Asian People ; Biomarkers, Tumor/blood ; China ; Databases, Factual ; Disease-Free Survival ; Humans ; Neoplasms/mortality ; Neoplasms/pathology ; Prognosis ; Proportional Hazards Models